BeOne Medicines (ONC) EBT Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 717.00 |
| Dec 31, 2025 | -46.00 |
| Sep 30, 2025 | 285.00 |
| Jun 30, 2025 | 570.00 |
| Mar 31, 2025 | 944.00 |
| Dec 31, 2024 | 225.00 |
| Sep 30, 2024 | 158.00 |
| Jun 30, 2024 | 2,099.00 |
| Mar 31, 2024 | 2,291.00 |
| Dec 31, 2023 | -8,464.00 |
| Sep 30, 2023 | 9,108.00 |
| Jun 30, 2023 | 1,351.00 |
| Mar 31, 2023 | 3,814.00 |
| Dec 31, 2022 | 2,882.00 |
| Sep 30, 2022 | 2,103.00 |
| Jun 30, 2022 | -2,586.00 |
| Mar 31, 2022 | 14,584.00 |
| Dec 31, 2021 | -7,344.00 |
| Sep 30, 2021 | 11,061.00 |
| Jun 30, 2021 | -33,061.00 |
| Mar 31, 2021 | 49,171.00 |
| Dec 31, 2020 | -385.00 |
| Sep 30, 2020 | 3,701.00 |
| Jun 30, 2020 | 18,337.00 |
| Mar 31, 2020 | -2,951.00 |
| Dec 31, 2019 | -4,652.00 |
| Sep 30, 2019 | -56,612.00 |
| Jun 30, 2019 | 15,939.00 |
| Mar 31, 2019 | 25,389.00 |
| Dec 31, 2018 | -20,170.00 |
| Sep 30, 2018 | 3,761.00 |
| Jun 30, 2018 | 2,842.00 |
| Mar 31, 2018 | 18,575.00 |
| Dec 31, 2017 | -57,110.00 |
| Jun 30, 2016 | -286,079.00 |
| Mar 31, 2016 | -376,924.00 |
| Dec 31, 2015 | 154,038.00 |
| Sep 30, 2015 | -60,565.00 |
| Jun 30, 2015 | 33,177.00 |